Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGooch & Housego Regulatory News (GHH)

Share Price Information for Gooch & Housego (GHH)

Share Price is delayed by 15 minutes
Get Live Data
1,020.00    28.00 (2.82%)
Bid:
1,010.00
Ask:
1,025.00
Spread: 15.00 (1.485%)
Market Cap: £279.18m
GHH Live PriceLast checked at - London Stock Exchange

Intraday Gooch & Housego Share Chart

Full-Year Trading Update

4 Oct 2011 07:00

RNS Number : 4702P
Gooch & Housego PLC
04 October 2011
Β 

ο»Ώ

Β 

For immediate release

4 October 2011

Β 

Β 

Gooch & Housego PLC

("G&H" or the "Company")

Β 

Full-Year Trading Update

Β 

Gooch & Housego PLC, the specialist manufacturer of optical components & systems, today announces that results for the year ended 30 September 2011will be in line with market expectations. Preliminary results will be announced on 29 November 2011.

Β 

Favourable market conditions prevailed for the first three quarters of the year and strong demand was experienced across most market and product sectors. The acquisitions of EM4 and Crystal Technology during the second quarter contributed to revenue and profit growth and accelerated the diversification of the business. G&H's presence in the aerospace & defence, life sciences and telecommunications markets has been significantly enhanced, while the Company's market leadership in acousto-optics and electro-optics for industrial applications has also been reinforced. Given the fragile global economic environment we did anticipate some softening in demand in the final quarter, although this has been confined to certain product sectors and geographical markets. Greater diversification and growth in new markets has mitigated some of the effects of the slowing demand in other sectors.

Β 

The integration of the new acquisitions is progressing well. The rationale for G&H's acquisition of EM4 was demonstrated by a number of significant contract wins for strategic defence programs including the recent award of a $3+ million contract by a large US defence contractor for the first phase of the design, development and supply of fibre optic systems. Plans to duplicate G&H Torquay's passive fibre optics technology at EM4's Boston site, in order to access the large US aerospace & defence market for these products, are already well-advanced with the first products expected to be available for qualification testing in early 2012.

Β 

Crystal Technology has performed strongly during the first six months of G&H ownership, with revenues from all major markets exceeding original plan. The transfer of crystal growing from the Crystal Technology facility in Palo Alto to G&H's Cleveland operation - a major undertaking requiring the fitting out of a new 30,000 square foot facility - is making good progress. The facility is essentially complete and the first crystals have been grown. It is expected that production will be fully transferred by the end of the calendar year.

Β 

Gareth Jones, Chief Executive of Gooch & Housego commented: -

Β 

"During the past twelve months we have made progress towards achieving the key strategic and commercial objectives of greater diversification and strong organic and acquisitive growth. The uncertain economic climate will present challenges in the coming year but Gooch & Housego is well-positioned to deliver the next phase of its strategy as we seek to leverage the exceptional products, technologies and capabilities that the company now has to offer."

Β 

For further information please contact:

Β 

Gareth Jones/Andrew Boteler, 01460 256440

Tim Thompson/Nicola Cronk, Buchanan, 020 7466 5000

Patrick Robb/James Grace, Investec Bank plc, 020 7597 5970

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
TSTFSDFMDFFSEDS
Date   Source Headline
15th Aug 20242:05 pmRNSDirector/PDMR Shareholding
15th Aug 20247:00 amRNSTrading Update
7th Aug 20248:48 amRNSDirector/PDMR Shareholding
31st Jul 202411:34 amRNSHolding(s) in Company
30th Jul 202412:17 pmRNSHolding(s) in Company
29th Jul 20248:56 amRNSHolding(s) in Company
11th Jun 202412:57 pmRNSNotification of Major Holdings
4th Jun 20242:06 pmRNSDirector/PDMR Shareholding
4th Jun 20247:00 amRNSInterim Results
31st May 20249:05 amRNSBoard Changes
13th May 20247:00 amRNSNotification of Half Year Results
4th Apr 20247:00 amRNSHalf Year Trading Update
18th Mar 20242:36 pmRNSDivestment of EM4
29th Feb 20247:00 amRNSDirector/PDMR Shareholding
27th Feb 20243:26 pmRNSNotification of Major Holdings
22nd Feb 20244:07 pmRNSNotification of Major Holdings
21st Feb 202412:31 pmRNSResult of AGM
21st Feb 202410:28 amRNSDirector/PDMR Shareholding
21st Feb 20249:43 amRNSDirector/PDMR Shareholding
21st Feb 20247:00 amRNSAGM Trading Update
12th Jan 20247:00 amRNSAnnual Report and Notice of AGM
10th Jan 20247:00 amRNSGrant of LTIP Awards
9th Jan 202411:53 amRNSNotification of Major Holdings
8th Jan 20243:57 pmRNSNotification of Major Holdings
4th Jan 20243:20 pmRNSDirector/PDMR Shareholding
5th Dec 20237:00 amRNSResults for the year ended 30 September 2023
8th Nov 20237:00 amRNSNotification of Full Year Results
23rd Oct 20232:23 pmRNSHolding(s) in Company
3rd Oct 20237:00 amRNSFull Year Trading Update
2nd Oct 20232:44 pmRNSHolding(s) in Company
9th Aug 20236:15 pmRNSDirector/PDMR Shareholding
31st Jul 20238:22 amRNSHolding(s) in Company
21st Jul 202311:58 amRNSCompletion of Acquisition and Issue of Equity
19th Jul 20237:00 amRNSAcquisition of Artemis Optical
23rd Jun 20234:11 pmRNSHolding(s) in Company
21st Jun 202310:26 amRNSDirector/PDMR Shareholding
20th Jun 20236:00 pmRNSAcquisition of GS Optics
6th Jun 20237:00 amRNSInterim Results
23rd May 20237:00 amRNSNotification of Half Year Results
3rd May 20238:56 amRNSIssue of Equity
4th Apr 20237:00 amRNSHalf Year Trading Update
30th Mar 20239:33 amRNSHolding(s) in Company
15th Mar 202312:00 pmRNSAppointment of Non-Executive Director
3rd Mar 20234:37 pmRNSHolding(s) in Company
2nd Mar 20231:10 pmRNSHolding(s) in Company
1st Mar 20239:44 amRNSHolding(s) in Company
22nd Feb 20231:50 pmRNSResult of AGM
22nd Feb 20237:00 amRNSAGM Trading Update
8th Feb 202312:59 pmRNSHolding(s) in Company
9th Jan 202311:44 amRNSGrant of LTIP Awards

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.